Back
Xeris Biopharma Holdings, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
XERS
Xeris Biopharma Holdings, Inc.
Last Price:
$6.11
Seasonality Move:
8.87%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and XERS is experiencing slight selling pressure.
Xeris Biopharma Holdings, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.64 | Sell |
| 20-day SMA: | 6.9 | Sell |
| 50-day SMA: | 7.21 | Sell |
| 200-day SMA: | 6.82 | Sell |
| 8-day EMA: | 5.67 | Buy |
| 20-day EMA: | 3.64 | Buy |
| 50-day EMA: | 1.82 | Buy |
| 200-day EMA: | 0.51 | Buy |
Xeris Biopharma Holdings, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.81 | Buy |
| Relative Strength Index (14 RSI): | 30.4 | Sell |
| Chaikin Money Flow: | -1295165 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.66 - 7.32) | Sell |
| Bollinger Bands (100): | (6.7 - 8.5) | Sell |
Xeris Biopharma Holdings, Inc. Technical Analysis
| Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings, Inc. Stock
Is Xeris Biopharma Holdings, Inc. Stock a Buy?
-
Xeris Biopharma Holdings, Inc. share price is 6.12 while XERS 8-day simple moving average is 6.64, which is a Sell signal.
-
The stock price of XERS is 6.12 while Xeris Biopharma Holdings, Inc. 20-day SMA is 6.90, which makes it a Sell.
-
Xeris Biopharma Holdings, Inc. 50-day simple moving average is 7.21 while XERS share price is 6.12, making it a Sell technically.
-
XERS stock price is 6.12 and Xeris Biopharma Holdings, Inc. 200-day simple moving average is 6.82, creating a Sell signal.
XERS Technical Analysis vs Fundamental Analysis
Sell
43
Xeris Biopharma Holdings, Inc. (XERS)
is a Sell
Is Xeris Biopharma Holdings, Inc. a Buy or a Sell?
-
Xeris Biopharma Holdings, Inc. stock is rated a SellThe current Xeris Biopharma Holdings, Inc. [XERS] share price is $6.12. The Score for XERS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Xeris Biopharma Holdings, Inc. Stock Info
Market Cap:
1B
Price in USD:
6.12
Share Volume:
5.9M
Xeris Biopharma Holdings, Inc. 52-Week Range
52-Week High:
10.08
52-Week Low:
3.59
Sell
43
Xeris Biopharma Holdings, Inc. (XERS)
is a Sell
Xeris Biopharma Holdings, Inc. Share Price Forecast
-
What is the Xeris Biopharma Holdings, Inc. stock price today?The Xeris Biopharma Holdings, Inc. stock price is 6.12 USD today.
-
Will XERS stock go up or go down?Xeris Biopharma Holdings, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Xeris Biopharma Holdings, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings, Inc. is overvalued.
Is Xeris Biopharma Holdings, Inc. Stock a Buy?
-
Xeris Biopharma Holdings, Inc. share price is 6.12 while XERS 8-day exponential moving average is 5.67, which is a Buy signal.
-
The stock price of XERS is 6.12 while Xeris Biopharma Holdings, Inc. 20-day EMA is 3.64, which makes it a Buy.
-
Xeris Biopharma Holdings, Inc. 50-day exponential moving average is 1.82 while XERS share price is 6.12, making it a Buy technically.
-
XERS stock price is 6.12 and Xeris Biopharma Holdings, Inc. 200-day simple moving average is 0.51, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings, Inc.
Is Xeris Biopharma Holdings, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.18 per share.
Technical Analysis of Xeris Biopharma Holdings, Inc.
Should I short Xeris Biopharma Holdings, Inc. stock?
-
XERS Moving Average Covergence Divergence (MACD) indicator is 1.81, suggesting Xeris Biopharma Holdings, Inc. is a Buy
-
Xeris Biopharma Holdings, Inc. Relative Strength Index (RSI) is 30.4, which suggest Xeris Biopharma Holdings, Inc. is oversold
-
The Bollinger Bands (25) for Xeris Biopharma Holdings, Inc. is (6.66 - 7.32), which suggest Xeris Biopharma Holdings, Inc. is a Sell
-
The Bollinger Bands (100) for Xeris Biopharma Holdings, Inc. is (6.7 - 8.5), which suggest Xeris Biopharma Holdings, Inc. is a Sell
* Xeris Biopharma Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.